Delivery Order SPE2DB22D3004-SPE2DB24FPQ63
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,199.97 firm fixed price delivery order is for the procurement of 4563912253 CYANOKIT 5 GRAM VIALS, a specialized pharmaceutical product, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award is for the delivery of CYANOKIT 5 gram vials, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,964.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of March 14, 2025 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,813.59 delivery order is for the supply of CYANOKIT 5 gram vials. The contract has a firm fixed price and an ultimate completion date of August 9, 2024. This award is not associated with any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,303.85 firm-fixed-price delivery order is for CYANOKIT 5 gram vials, a medication used to treat cyanide poisoning. The contract has an ultimate completion date of July 1, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYANOKIT 5 GRAM VIALS, a pharmaceutical product, with a ceiling value of $3,964.68. The contract is a Delivery Order, with a Firm Fixed Price pricing type. The period of performance extends through June 12, 2025. This award is not associated with a set-aside designation, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567712162 - CYANOKIT 5 GRAM VIALS, a critical medical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,982.31 and a period of performance through March 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyanokit 5 gram vials. The delivery order is valued at $5,157.76 and has a completion date of September 19, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen is the prime contractor and is responsible for providing the Cyanokit vials, which are a critical medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 16, 2026, for Cyanokit 5 gram vials with a ceiling value of $1,711.73 and a completion date of January 20, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and is funded by the Defense Logistics Agency (DLA), which serves as the primary procurement vehicle for medical supplies supporting military and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $5,116.76 firm fixed price delivery order is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. The contract has no set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a delivery order valued at $1,443.79. The contract has a period of performance through March 12, 2024 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPQ63Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,912.59 firm fixed price delivery order is for the supply of CYANOKIT 5 gram vials, a specialized pharmaceutical product. The contract has a performance period through March 12, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued against that IDC contract. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division, valued at up to $750,000 through May 2024, to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/11/24 |